Juyeon Ham
Overview
Explore the profile of Juyeon Ham including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim H, Park J, Baek M, Kim H, Ji H, Yun S, et al.
Cancers (Basel)
. 2022 Mar;
14(5).
PMID: 35267540
Background: Tamoxifen (tam) is widely used to treat estrogen-positive breast cancer. However, cancer recurrence after chemotherapy remains a major obstacle to achieve good patient prognoses. In this study, we aimed...
2.
Jeong D, Ham J, Kim H, Kim H, Ji H, Yun S, et al.
Am J Cancer Res
. 2021 Jul;
11(6):2568-2589.
PMID: 34249416
Epigenetic events have successfully explained the cause of various cancer types, but little is known about tamoxifen resistance (TamR) that induces cancer recurrence. In this study, genome-wide methylation analysis in...
3.
Kim H, Jeong D, Ham J, Kim H, Ji H, Choi E, et al.
Oxid Med Cell Longev
. 2020 May;
2020:9490567.
PMID: 32454947
Cold atmospheric plasma (CAP) has been recognized as a potential alternative or supplementary cancer treatment tool, which is attributed by its selective antiproliferation effect on cancer cells over normal cells....
4.
Ham J, Jeong D, Park S, Kim H, Kim H, Kim S
J Ginseng Res
. 2019 Nov;
43(4):625-634.
PMID: 31700260
Background: Ginsenoside Rg3, a derivative of steroidal saponins abundant in ginseng, has a range of effects on cancer cells, including anti-cell proliferation and anti-inflammation activity. Here, we investigate two long...
5.
Jeong D, Ham J, Park S, Kim H, Kim H, Ji H, et al.
Am J Chin Med
. 2019 Oct;
47(7):1643-1658.
PMID: 31645124
Ginsenoside Rh2, a major bioactive ingredient abundant in red ginseng, has an antiproliferative effect on various cancer cells. In this study, we report a novel long noncoding RNA, C3orf67-AS1, which...
6.
Jeong G, Bae H, Jeong D, Ham J, Park S, Kim H, et al.
Sci Rep
. 2018 Aug;
8(1):12922.
PMID: 30150751
In our previous study, the Kelch domain-containing 7B (KLHDC7B) was revealed to be hypermethylated at the promoter but upregulated in breast cancer. In this study, we identified a long non-coding...
7.
Ham J, Lee S, Lee H, Jeong D, Park S, Kim S
Am J Chin Med
. 2018 Aug;
46(6):1333-1355.
PMID: 30149757
Ginsenoside Rg3 is a key metabolite of ginseng and is known to inhibit cancer cell growth. However, the epigenetics of CpG methylation and its regulatory mechanism have yet to be...
8.
Lee S, Park S, Lee H, Jeong D, Ham J, Choi E, et al.
Free Radic Biol Med
. 2018 Aug;
126:133-141.
PMID: 30096431
Cold atmospheric plasma (CAP) has gained attention for use in cancer treatment owing to its ability to preferentially induce cancer cell death; however, the involved molecular mechanism remains to be...
9.
Jeong D, Ham J, Park S, Lee S, Lee H, Kang H, et al.
Sci Rep
. 2017 Nov;
7(1):15425.
PMID: 29133945
MicroRNA-7 (miR-7) is a non-coding RNA of 23-nucleotides that has been shown to act as a tumor suppressor in various cancers including breast cancer. Although there have been copious studies...
10.
Lee S, Lee H, Jeong D, Ham J, Park S, Choi E, et al.
Free Radic Biol Med
. 2017 Jul;
110:280-290.
PMID: 28666851
Cancer recurrence, which is frequently accompanied by chemotherapy, has been a challenge in cancer treatment. This study was carried out to examine the potential applications of the reactive oxygen species...